Management of cardiovascular risk in clozapine patients: how can we optimise it?

被引:0
|
作者
Hawes, A. [1 ]
Tran, T. [1 ]
Albuloushi, A. [1 ]
Parmar, S. [2 ]
Ally, B. [2 ]
Santos, J. M. Serrano [1 ]
机构
[1] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia
[2] Queensland Hlth, Metro South & West Moreton, Brisbane, Qld, Australia
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:E40 / E40
页数:1
相关论文
共 50 条
  • [41] How "low" can we go: Assessing risk in chest pain patients
    Hsieh, M
    Auble, TE
    Yealy, DM
    ACADEMIC EMERGENCY MEDICINE, 2001, 8 (07) : 754 - 755
  • [42] Can we improve cardiovascular risk assessment with ultrasounds?
    Sprynger, Muriel
    Girbea, Alexandra
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2020, 21 (04) : 397 - 398
  • [43] HOW MUCH DIFFERENCE CAN WE MAKE BY STANDARDIZED ASSERTIVE MANAGEMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A REAL-LIFE CLINIC STUDY
    Bakshi, Jyoti
    Isenberg, David A.
    Rahman, Anisur
    RHEUMATOLOGY, 2016, 55 : 166 - 166
  • [44] If we can simulate it, we can insure it: An application to longevity risk management
    Boyer, M. Martin
    Stentoft, Lars
    INSURANCE MATHEMATICS & ECONOMICS, 2013, 52 (01): : 35 - 45
  • [45] Preeclampsia and future cardiovascular disease in women: How good are the data and how can we manage our patients?
    Seely, Ellen W.
    Tsigas, Eleni
    Rich-Edwards, Janet W.
    SEMINARS IN PERINATOLOGY, 2015, 39 (04) : 276 - 283
  • [46] How 'beetles' can optimise ship inspection
    不详
    MER-MARINE ENGINEERS REVIEW, 1997, : 19 - 19
  • [47] How can filtration optimise the production of biofuels?
    不详
    FILTRATION + SEPARATION, 2022, 59 (02) : 24 - 25
  • [48] How we treat and diagnose patients at high cardiovascular risk in primary health care?
    Serafin, A. Agnieszka
    Niewada, M.
    Glowczynska, R.
    Starczewska, M.
    Pietrasik, A.
    Filipiak, K. J.
    Opolski, G.
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2012, 11 : S40 - S41
  • [49] Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
    Vrablik, Michal
    Dlouha, Dana
    Todorovova, Veronika
    Stefler, Denes
    Hubacek, Jaroslav A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [50] Biomarkers of schizophrenia: can we optimise patient outcomes?
    Falkai, P.
    EUROPEAN PSYCHIATRY, 2014, 29